Spots Global Cancer Trial Database for Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization

Official Title: Measurement of Adherence and Health-related Quality of Life, and Health-Care Resource Utilization During Anticoagulation Therapy in Cancer-Related Venous Thromboembolism (VTE)

Study ID: NCT03407469

Conditions

Cancer-related Venous Thromboembolism

Interventions

Questionnaires

Study Description

Brief Summary: The goal of this research study is to learn about the quality of life, experiences with treatment, and healthcare costs of patients who are receiving long-term treatment for venous thromboembolism (VTE) that is related to cancer. This is an investigational study. Up to 260 participants will be enrolled in this multicenter study. Up to 170 will take part in MD Anderson.

Detailed Description: If you agree to take part in this study, you will complete 2 questionnaires either at an already-scheduled clinic visit or over the phone at the time you join this study and then about 30 days, 3 months, 6 months, and 12 months after that. These questionnaires will be about your quality of life and experiences with treatment for VTE. It should take less than 10 minutes to complete the questionnaires each time. Information from your medical record may also be collected at these time points. Your participation will be over after the last questionnaires are completed at about 12 months after you enroll in the study.